Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1172
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease ; volume:10 ; number:1 ; day:2 ; month:11 ; year:2015 ; pages:1 ; date:12.2015
Orphanet journal of rare diseases ; 10, Heft 1 (2.11.2015), 1, 12.2015
- Urheber
-
Raya-Cruz, Manuel
Buades-Reines, Juan
Gallego-Lezaun, Cristina
Ferullo, Ignacio
Ripoll-Vera, Tomas
Uson-Martín, Mercedes
Andreu-Serra, Hernan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1750-1172-10-S1-P29
- URN
-
urn:nbn:de:101:1-2020100521520725509424
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Raya-Cruz, Manuel
- Buades-Reines, Juan
- Gallego-Lezaun, Cristina
- Ferullo, Ignacio
- Ripoll-Vera, Tomas
- Uson-Martín, Mercedes
- Andreu-Serra, Hernan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Vasculopathy in transthyretin Val30Met familial amyloid polyneuropathy
Ocular manifestations of transthyretin-related familial amyloid polyneuropathy
Patient-reported outcomes on familial amyloid polyneuropathy (FAP)
Psychopathological Dimensions in Portuguese Subjects with Transthyretin Familial Amyloid Polyneuropathy
Brazilian consensus for diagnosis, management and treatment of transthyretin familial amyloid polyneuropathy
Specific ophtalmologic changes in late onset familial amyloid polyneuropathy (FAP) portuguese patients
Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy
Patient-specific induced pluripotent stem cell-based modelling of transthyretin-related Familial Amyloidotic Polyneuropathy
Positive real-world effectiveness of tafamidis for delaying disease progression in transthyretin familial amyloid polyneuropathy
Epidemiology of transthyretin-associated familial amyloid polyneuropathy in the Majorcan area: Son Llàtzer Hospital descriptive study
Familial amyloidotic polyneuropathy associated with the transthyretin CYS 114 gene in a Russian pair of monozygotic twins
Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm
Vasculopathy in transthyretin Val30Met familial amyloid polyneuropathy
Ocular manifestations of transthyretin-related familial amyloid polyneuropathy
Patient-reported outcomes on familial amyloid polyneuropathy (FAP)
Psychopathological Dimensions in Portuguese Subjects with Transthyretin Familial Amyloid Polyneuropathy
Brazilian consensus for diagnosis, management and treatment of transthyretin familial amyloid polyneuropathy
Specific ophtalmologic changes in late onset familial amyloid polyneuropathy (FAP) portuguese patients
Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy
Patient-specific induced pluripotent stem cell-based modelling of transthyretin-related Familial Amyloidotic Polyneuropathy
Positive real-world effectiveness of tafamidis for delaying disease progression in transthyretin familial amyloid polyneuropathy
Epidemiology of transthyretin-associated familial amyloid polyneuropathy in the Majorcan area: Son Llàtzer Hospital descriptive study
Familial amyloidotic polyneuropathy associated with the transthyretin CYS 114 gene in a Russian pair of monozygotic twins
Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm
Vasculopathy in transthyretin Val30Met familial amyloid polyneuropathy
Ocular manifestations of transthyretin-related familial amyloid polyneuropathy
Patient-reported outcomes on familial amyloid polyneuropathy (FAP)
Psychopathological Dimensions in Portuguese Subjects with Transthyretin Familial Amyloid Polyneuropathy
Brazilian consensus for diagnosis, management and treatment of transthyretin familial amyloid polyneuropathy
Specific ophtalmologic changes in late onset familial amyloid polyneuropathy (FAP) portuguese patients
Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy
Patient-specific induced pluripotent stem cell-based modelling of transthyretin-related Familial Amyloidotic Polyneuropathy
Positive real-world effectiveness of tafamidis for delaying disease progression in transthyretin familial amyloid polyneuropathy
Epidemiology of transthyretin-associated familial amyloid polyneuropathy in the Majorcan area: Son Llàtzer Hospital descriptive study
Familial amyloidotic polyneuropathy associated with the transthyretin CYS 114 gene in a Russian pair of monozygotic twins